Previous close | 3.4000 |
Open | 3.4000 |
Bid | 0.1000 |
Ask | 2.9000 |
Strike | 60.00 |
Expiry date | 2024-09-20 |
Day's range | 3.4000 - 3.4000 |
Contract range | N/A |
Volume | |
Open interest | 1.23k |
Key Insights Crinetics Pharmaceuticals will host its Annual General Meeting on 7th of June CEO R. Struthers' total...
On May 28, 2024, Stephen Betz, Chief Scientific Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), sold 3,000 shares of the company at a price of $47.49 per share.
SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced the appointment of Robert M. Cuddihy, M.D., as senior vice president of Medical Affairs. Dr. Cuddihy is a board-certified physician in endocrinology, diabetes and metabolism with more than 30 years of experience spanning clinical practice and pharmaceutical industry medical affairs. “Dr. Cuddihy’s wealth of knowledge and experience both as a practicing physician in endocrinology and workin